Biotech Values

[zipjet]

>>I have a hard time believing that the poster in question was/is really short.

Doc has not told me he shorted MNTA. But it looked like he was saying so on the RPRX thread. I do know and like him.

He is well informed on RPRX.

His appreciation of MNTA is flawed. But I would not expect that to keep him or other hedge funds from shorting a money-burning biotech that has been rejected by the FDA and had a dead-cat bounce. That is what it looks like - however superficial that view may turn out to be.

Add to the mix that the shorts made a bundle on the stock, have reduced the shorting by millions of shares and see the opportunity to heavily short it again at a point in time where institutional holders have reduced their support. What will the price of the stock do if another 4 million shares are shorted opportunistically with no uptick rule? BS seems to support the short trade with their comments. Since no significant* news is expected in the next couple of months there is time for the shorts to develop this trade.

ij

* BTW - I do not consider the Appeal a significant news item if the lower court decision is upheld. A reversal or another new trial would be a significant negative.